Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PIUR tUS

Financiado

Cerrado

Tomographic 3D Ultrasound for Safe and More Cost Effective Vascular Diagnostics...

Tomographic 3D Ultrasound for Safe and More Cost Effective Vascular Diagnostics and Treatment Planning Annually, cardiovascular disease (CVD) causes over 4m deaths in Europe and 17.3m deaths globally, and is expected to grow to over 23.6m by 2030. It accounts for 40% of deaths in the EU and costs the EU economy almost €196bn each y... ver más

31/10/2019

IVS

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

INDEPENDENT VASCULAR SERVICES LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 6 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-10-31

FTIPilot-01-2016: Fast Track to Innovation Pilot

I+D

Cerrada hace 8 años

0% 78% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

6 Participantes

IVS

551.58K€ | Lider

FRANCISCO ALBERO

1.07M€ | Participante

UNIVERSITY OF MANCHESTER

239.21K€ | Participante

ImFusion

174.83K€ | Participante

Proyectos interesantes

piur tUS

Medical Technol...

Data Science

71K€ Cerrado

TIN2009-10770

Medical Technol...

Data Science

71K€ Cerrado

iNNOGING

Medical Technol...

Data Science

71K€ Cerrado

CSI

Medical Technol...

Data Science

15M€ Cerrado

UVOLUMES

Medical Technol...

Data Science

673K€ Cerrado

MAP-IN-HEART

Medical Technol...

Data Science

150K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 28 meses Fecha Inicio: 2017-06-07
Fecha Fin: 2019-10-31

Líder del proyecto

INDEPENDENT VASCULAR SERVICES LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Annually, cardiovascular disease (CVD) causes over 4m deaths in Europe and 17.3m deaths globally, and is expected to grow to over 23.6m by 2030. It accounts for 40% of deaths in the EU and costs the EU economy almost €196bn each year. 2D ultrasound scans are currently the primary choice for vascular diagnostics. Due to low sensitivity, a limited field of action and the lack of volume information, patients are often referred for CTa, MRa and catheter angiography for the detailed imaging required for diagnosis and treatment planning. Referrals delay treatment, exposes the patient to risks associated with radiation and contrast mediums and increases costs. This presents a need to improve the speed and safety of the diagnosis of vascular conditions for rapid treatment, as well as to improve workflow efficiency and reduce costs. The project consortium will further develop the piur tUS system, a 3D freehand tomographic US system capable of rapid, safe and accurate reconstructive 3D quantifiable vascular imaging. It will provide a low cost and reproducible imaging solution that will reduce the need for referrals and be an effective preventative screening tool for CVD. We aim to complete and publish the results from 4 CVD clinical studies to generate the clinical evidence required for CE marking and clinical validation for market uptake. The 4 clinical applications studied will provide a solution for conditions most frequently referred for detailed 3D imaging to maximise the cost-benefit to clinics of purchasing the piur tUS system. The project consortium combines piur imaging’s expertise in medical device development and commercialisation with 3D imaging specialist ImFusion GmbH and medical device product development and manufacturing experts ACMIT. The clinical input for the product development and the clinical studies will be provided by our consortium partners, Independent Vascular Services Ltd and the Institute for Cardiovascular Science: University of Manchester

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores